Founded in 2000, Flagship Pioneering is a venture capital investment firm that prefers to invest in the health technologies and life science sectors. The firm is based in Cambridge, Massachusetts.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Vesalius Therapeutics | 01-Mar-2022 | Early Stage VC | 0000 | Drug Discovery | Startup | 000000 000000 00.0 |
00000000 000000000 | 18-Nov-2021 | 00000 00000 | 00000 | Discovery Tools (Healthcare) | Generating Revenue | 00000000 000 00000000 00.0 |
0000 | 15-Nov-2021 | 0000 | 00000 | Drug Discovery | Generating Revenue | 0000 000000 |
0000000 | 09-Nov-2021 | 00000 00000 | 0000 | Drug Discovery | Startup | 000000 00000000 00.0 |
0000000 000000 | 02-Sep-2021 | 00000 00000 | 0000 | Other Devices and Supplies | Generating Revenue | 000000 000000 00.0 |
0000000 | 28-Jul-2021 | 00000 00000 | 00000 | Drug Discovery | Startup | 0000 00000000 00.0 |
0000 000000000000 | 28-Jul-2021 | 00000 00000 | 00000 | Biotechnology | Generating Revenue | 0000 000000000 00.0 |
00000 00000000000 | 10-Jun-2021 | 00000 00000 | 0000 | Drug Discovery | Startup | 000000000 000000 00.0 |
Inari | 12-May-2021 | Later Stage VC | 00000 | Other Agriculture | Generating Revenue | 000000 00000000 00.0 |
Repertoire Immune Medicines | 13-Apr-2021 | Later Stage VC | 00000 | Biotechnology | Generating Revenue | 0000000 0000 00 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Novomer | 11-Aug-2021 | Merger/Acquisition | 00000 |
00000 000000000000 | 30-Jul-2021 | 000 | 00000 |
000000 000000 0000 | 27-Jul-2021 | 000000000000000000 | 0000 |
00000 | 01-Jun-2021 | 000000000 00000000 | |
0000000 0000000 | 01-Jun-2021 | 000000000 00000000 | |
00000 00000000000 | 28-Apr-2021 | 000 00 00000000 | |
0000000 | 10-Mar-2021 | 000000000000000000 | 000.00 |
000000 | 12-Feb-2021 | 000000 0000000000 | 000.00 |
Sana Biotechnology | 04-Feb-2021 | IPO | 00000 |
Sigilon Therapeutics | 04-Dec-2020 | IPO | 00000 |
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
This information is available in the PitchBook Platform. To explore Flagship Pioneering‘s full profile, request access.
Request a free trialInvestments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialName | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Noubar Afeyan Ph.D | Co-Founder & Chief Executive Officer | 00 | 0 | 00 | Cambridge, MA |
Chuck Carelli | Chief Financial Officer | Cambridge, MA | |||
Jeffery Moore | Chief Financial Officer, Flagship Labs | Cambridge, MA | |||
Robert Rosiello | Executive Partner & Chief Operating Officer | 0 | Cambridge, MA | ||
Douglas Cole MD | Managing Partner | 00 | 0 | 0 | Cambridge, MA |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
The Invus Group | 7 | 0 | |||
ARCH Venture Partners | 0 | 0 | 0 | ||
Alaska Permanent Fund | 0 | 0 | |||
Longevity Vision Fund | 0 | 0 | |||
T. Rowe Price | 0 | 0 |